Overview

Capsaicin for Post-stroke Dysphagia

Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
Randomised, double blind, Phase 2 Trial to evaluate the efficacy of oral Capsaicin in patients with post-stroke dysphagia in the (sub-)acute setting.
Phase:
Phase 2
Details
Lead Sponsor:
Georg Kägi, MD
Collaborators:
Cantonal Hospital of Aarau, Switzerland
University Hospital, Basel, Switzerland
Treatments:
Capsaicin
Pharmaceutical Solutions